Publisher
Springer Science and Business Media LLC
Reference8 articles.
1. Kao TW, Lee KH, Chan WP, Fan KC, Liu CW, Huang YC (2022) Continuous use of metformin in patients receiving contrast medium: What is the evidence? A systematic review and meta-analysis. Eur Radiol 32:3045
2. Jung J, Cho YY, Jung JH et al (2019) Are patients with mild to moderate renal impairment on metformin or other oral anti-hyperglycaemic agents at increased risk of contrast-induced nephropathy and metabolic acidosis after radiocontrast exposure? Clin Radiol 74:651.e1
3. Kim SK, Jung J, Jung JH, Kim KY, Baek JH, Hahm JR (2016) The association between use of metformin and change in serum CO2 level after administration of contrast medium. Clin Radiol 71:532
4. Namazi MH, AlipourParsa S, Roohigilani K et al (2018) Is it necessary to discontinue metformin in diabetic patients with GFR > 60 mL/min per 1.73 m2 undergoing coronary angiography: a controversy still exists? Acta Biomed 89:227
5. Oktay V, Calpar Çıralı İ, Sinan Ü, Yıldız A, Ersanlı MK (2017) Impact of continuation of metformin prior to elective coronary angiography on acute contrast nephropathy in patients with normal or mildly impaired renal functions. Anatol J Cardiol 18:334